Kuwait Times, 12 May 2025: Kuwait Ministerial Decision No 93/2025, has been issued approving new pricing for 69 medicines and pharmaceutical products in private pharmacies.

The decision follows recommendations made by the Drug Pricing Committee. These approved prices are for a wide range of therapeutic categories. These include medications for cancer, including leukemia, as well as treatments for diabetes, hypertension, high cholesterol, and cardiovascular diseases. It also covers anticoagulants, antidepressants, antiepileptics, antibiotics, antifungals, antivirals, asthma treatments, osteoporosis drugs, thyroid medications, dermatological preparations, Alzheimer’s and dementia treatments, obesity medications, and migraine relief drugs.

The new decision complements Kuwait Ministerial Decision No. 74/2023.

For more news and content, try Lexis Middle East. Click on lexis.ae/demo to begin your free trial of Lexis® Middle East platform.

You can also explore the legal landscape by subscribing to our Weekly Newsletter.

Want to learn more about Lexis® Middle East? Visit https://www.lexis.ae/lexis-middle-east-law/.